References
- Godwin JD. Carcinoid tumors. An analysis of 2837 cases. Cancer 1975; 36: 560–569.
- Norton JA, Doppman JL, Jensen RT. Cancer of the endocrine system. In: Cancer Principles and Practice of Oncology. Ed. De Vita, Hellman, Rosenberg Philadelphia: Lippincott Comp. 1989; 39: 1303–1314.
- Cabano F, Cebrelli C, Barbiggia C, Cebrelli CF, Sfondrini P. Primary malignant tumors of the small intestine. A clinical report. Min Chir 1990; 45: 821–826.
- Feldman JM. Carcinoid tumors and syndrome. Sem Oncol 1987; 14: 237–246.
- Soga J. Malignant characteristics of gastrointestinal carcinoids. J Exp Clin Cancer Res 1989; 8: 131–136.
- Sjblom SM. Clinical presentation and prognosis of gastrointestinal carcinoid tumors. Scand J Gastroenterol 1988; 23: 779–787.
- Kvols LK. Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy. Am J Med 1986; 81: 49–54.
- Chernicoff D, Bukowki RM, Groppej CW, Hewlett JS. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozo-tocin. Cancer Treat Rep 1979; 63: 795–796.
- Moertel CG. Chemotherapy of gastrointestinal cancers. Clin Gastroenterol 1986; 5: 777–783.
- Legha SS, Valdivieso M, Nelson RS, Benjamin RS, Bodey GP. Chemotherapy for metastatic carcinoid tumors: experiencies with 32 patients and a review of literature. Cancer Treat Rep 1977; 61: 1699–1703.
- Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214.
- Kvols LK. Therapeutic consideration for the malignant carcinoid syndrome. Acta Oncol 1989; 28: 443–448.
- Moertel CG, Hanley JA. Combination chemotherapy trials in metastatic carcinoid syndrome. Cancer Clin Trials 1979; 2: 327–333.
- Bukowski RM, Johnson KG, Peterson RF, Stephens RL, Rivkin SE, Neilan B, Costanzi JH. A phase II trial of combination chemotherapy in patients with metastatic carcin-oid tumors. A southwest oncology group study. Cancer 1987; 60: 2891–2895.
- Harris AL. Chemotherapy for the carcinoid syndrome. Cancer Chemother Pharmacol 1981; 5: 133–138.
- Moertel CG, Rubin J, Kvols LK. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte a-interferon. J Clin Oncol 1989; 7: 865–868.
- Oberg K, Norheim I, Aim G. Treatment of malignant carcinoid tumors: a randomized controlled study of streptozo-cin plus 5FU and human leukocyte interferon. Eur J Cancer Clin Oncol 1989; 25: 1475–1479.
- Nobin A, Lindblom A, Mansson B, Sundberg M. Interferon treatment in patients with malignant carcinoids. Acta Oncol 1989; 28: 445–449.
- Hill GJ. Carcinoid tumors: pharmacological therapy. Oncology 1971; 25: 329–343.
- Vinik AI, Thompson N, Eckhauser F, Moattari AR. Clinical features of carcinoid syndrome and the use of soma-tostatin analogue in its management. Acta Oncol. 1989; 28: 389–402.